1,380 results on '"Bukh, Jens"'
Search Results
202. Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non‐target sites, for DAA‐based treatment and retreatment outcome
203. Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity
204. Identification of specific amino acid residues in the border disease virus glycoprotein E2 that modify virus growth in pig cells but not in sheep cells
205. Insights into the unique characteristics of hepatitis C virus genotype 3 revealed by development of a robust sub-genomic DBN3a replicon
206. VIRAL HEPATITIS: Cell-culture-derived HCV —a promising vaccine antigen
207. HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4.
208. Genetic variations in the innate immune system and differences in outcome of hepatitis C virus infection: a candidate gene association study: 991
209. Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression
210. Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
211. In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C VirusΔσ
212. In vitro efficacy of Artemisinin-based treatments against SARS-CoV-2
213. Efficient culture of SARS-CoV-2 in human hepatoma cells enhances viability of the virus in human lung cancer cell lines permitting the screening of antiviral compounds
214. Analysis of Virus Population Profiles within Pigs Infected with Virulent Classical Swine Fever Viruses: Evidence for Bottlenecks in Transmission but Absence of Tissue-Specific Virus Variants
215. Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity
216. Influence of baseline resistance on treatment outcome in patients treated for chronic hepatitis C in Denmark: a nationwide study
217. An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
218. Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis
219. Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency
220. Identification of Novel Determinants of Neutralization Epitope Shielding for Hepatitis C Virus in Vitro
221. Evolutionary selection of pestivirus variants with altered or no microRNA dependency
222. Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell–Based Vaccine Development
223. Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c
224. Reflections on the History of HCV: A Posthumous Examination
225. Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent
226. Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark
227. In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone
228. Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models
229. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs#†
230. High recombination rate of hepatitis C virus revealed by a green fluorescent protein reconstitution cell system.
231. The quasispecies of hepatitis C virus and the host immune response
232. Hepatitis C Virus Replication in Cell Culture
233. Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain
234. Immunity Against the GBV-B Hepatitis Virus in Tamarins Can Prevent Productive Infection Following Rechallenge and Is Long-Lived
235. Development of a TaqMan Assay for the Six Major Genotypes of Hepatitis C Virus: Comparison With Commercial Assays
236. Long PCR Methodology
237. Long PCR Amplification of Large Fragments of Viral Genomes
238. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection
239. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes
240. How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure
241. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee
242. Importance of the polymerase chain reaction in the study of hepatitis C virus infection
243. Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes*
244. Genome sequence of an unknown subtype of hepatitis C virus genotype 6:Another piece for the taxonomic puzzle
245. Virus adaptation and selection following challenge of animals vaccinated against classical swine fever virus
246. Evolutionary pathways to persistence of highly fit and resistant hepatitis C virus protease inhibitor escape variants
247. In vitro neutralization assay using cultured hepatitis C virus
248. Full-length open reading frame amplification of hepatitis C virus
249. Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies
250. HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.